These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

75 related articles for article (PubMed ID: 11070693)

  • 1. [Assessment of usefulness of PCNA and oncoprotein p53 staining in prediction of the recurrences in subjects operated on for laryngeal carcinoma].
    Morawski K; Namysłowski G; Gabriel A; Pietrawska V; Ziółkowski A; Urbaniec P
    Otolaryngol Pol; 2000; 54(4):393-9. PubMed ID: 11070693
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Assessment of usefulness of PCNA and protein p53 in subjects with laryngeal cancer with local recurrence].
    Morawski K; Gabriel A; Namysłowski G; Pietrawska V; Ziółkowski A; Urbaniec P
    Otolaryngol Pol; 2000; 54 Suppl 31():174-7. PubMed ID: 10974877
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical application of proliferating cell nuclear antigen, oncoprotein p53 and tumor front grading analysis in patients operated on for laryngeal cancer.
    Morawski K; Gabriel A; Namyslowski G; Ziólkowski A; Pietrawska V; Steplewska K
    Eur Arch Otorhinolaryngol; 1999; 256(8):378-83. PubMed ID: 10525938
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ki-67 (MIB1), p53, and Lewis-X (LeuM1) as prognostic factors of recurrence in T1 and T2 laryngeal carcinoma.
    Sittel C; Eckel HE; Damm M; von Pritzbuer E; Kvasnicka HM
    Laryngoscope; 2000 Jun; 110(6):1012-7. PubMed ID: 10852523
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A comprehensive analysis of selected diagnostic methods with respect to their usefulness in evaluating the biology of neoplastic cells in patients with laryngeal cancer.
    Golusinski W; Olofsson J; Szmeja Z; Biczysko W; Krygier-Stojałowska A; Kulczyński B
    Eur Arch Otorhinolaryngol; 1999; 256(6):306-11. PubMed ID: 10456281
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Prognostic relevance of proliferation marker Ki-67 (MIB 1), PCNA and p53 in combined surgically and radiologically treated cancers of the oropharynx and mouth cavity].
    Sittel C; Ruiz S; Kvasnicka HM; Volling P; Jungehülsing M; Eckel HE
    Laryngorhinootologie; 2000 Feb; 79(2):86-92. PubMed ID: 10738715
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic value of cell proliferation markers, tumour suppressor proteins and cell adhesion molecules in primary squamous cell carcinoma of the larynx and hypopharynx.
    Liu M; Lawson G; Delos M; Jamart J; Chatelain B; Remacle M; Marbaix E
    Eur Arch Otorhinolaryngol; 2003 Jan; 260(1):28-34. PubMed ID: 12520353
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Proliferating cell nuclear antigen, p53, and c-erbB-2 expression in relation to clinicopathological variables and prognosis in cancer of the ampulla of Vater.
    Ajiki T; Kamigaki T; Hasegawa Y; Fujino Y; Suzuki Y; Takeyama Y; Ku Y; Kuroda Y
    Hepatogastroenterology; 2001; 48(41):1266-70. PubMed ID: 11677943
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression form of p53 and PCNA at the invasive front in oral squamous cell carcinoma: correlation with clinicopathological features and prognosis.
    Kato K; Kawashiri S; Yoshizawa K; Kitahara H; Okamune A; Sugiura S; Noguchi N; Yamamoto E
    J Oral Pathol Med; 2011 Oct; 40(9):693-8. PubMed ID: 21501231
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic value of PCNA and mutant p53 expression in laryngeal squamous cell carcinoma.
    Buyukbayram H; Cureoglu S; Arslan A; Işikakdogan AR
    Cancer Invest; 2004; 22(2):195-202. PubMed ID: 15199601
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Changes in expression of p53, proliferating cell nuclear antigen and bcl-2 in recurrent laryngeal cancer after radiotherapy.
    Lee BJ; Wang SG; Roh HJ; Goh EK; Chon KM; Park DY
    J Laryngol Otol; 2006 Jul; 120(7):579-82. PubMed ID: 16672091
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Expression of p53, p21, PCNA and COX-2 and its relationship with recurrence in the early-stage laryngeal cancer with negative surgical margin].
    Zeng R
    Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2016 Mar; 30(5):349-52, 356. PubMed ID: 27382672
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The expression of proliferating cell nuclear antigen (PCNA) and p 53 protein correlate with prognosis of patients with oral squamous cell carcinoma.
    Kurokawa H; Yamashita Y; Takeda S; Miura K; Murata T; Kajiyama M
    Fukuoka Igaku Zasshi; 1999 Jan; 90(1):6-13. PubMed ID: 10087668
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic value of expression of p53, proliferating cell nuclear antigen, and c-erbB-2 in laryngeal carcinoma.
    Micozkadioğlu D; Unal M; Pata YS; Baştürk M; Cinel L
    Med Sci Monit; 2008 Jun; 14(6):CR299-304. PubMed ID: 18509272
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Diagnostic and prognostic value of p53 oncogene and the selected neoplastic markers (Ki67, PCNA, DNA ploidy) of the ultrastructure in patients with laryngeal cancer].
    Golusiński W; Szmeja Z; Olofsson J; Biczysko W; Krygier-Stojałowska A; Majewski P
    Otolaryngol Pol; 1996; 50(6):607-17. PubMed ID: 9173391
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prediction of occult neck metastases in laryngeal carcinoma: role of proliferating cell nuclear antigen, MIB-1, and E-cadherin immunohistochemical determination.
    Franchi A; Gallo O; Boddi V; Santucci M
    Clin Cancer Res; 1996 Oct; 2(10):1801-8. PubMed ID: 9816133
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Immunohistochemical study of p53, p27 and PCNA expression in esophageal cancer].
    Sakurai K; Hata S; Amano S; Kimura T; Hori A; Sakamoto A; Kimizuka K; Mimatsu K; Nishio S; Miyake H; Shibata M; Fukuzawa M
    Gan To Kagaku Ryoho; 1998 Jul; 25(9):1269-72. PubMed ID: 9703805
    [TBL] [Abstract][Full Text] [Related]  

  • 18. p53, PCNA and Ki67 in laryngeal cancer.
    Golusiński W; Olofsson J; Szmeja Z; Majewski P
    Pol J Pathol; 1996; 47(4):175-82. PubMed ID: 9097709
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Y-box-binding protein-1 expression is not correlated with p53 expression but with proliferating cell nuclear antigen expression in non-small cell lung cancer.
    Yoshimatsu T; Uramoto H; Oyama T; Yashima Y; Gu C; Morita M; Sugio K; Kohno K; Yasumoto K
    Anticancer Res; 2005; 25(5):3437-43. PubMed ID: 16101161
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The prognostic value of proliferating cell nuclear antigen (PCNA) and p53 protein expression in patients with advanced nasopharyngeal carcinoma.
    Wang LF; Chai CY; Kuo WR; Tai CF; Lee KW; Ho KY
    Acta Otolaryngol; 2006 Jul; 126(7):769-74. PubMed ID: 16803719
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.